Vertex Pharmaceuticals Stock Soaring: Is More Upside Ahead?
Vertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
This intro covers scenarios where a price-weighted index may be appropriate and how it contrasts with alternative indexing methods.
22,669 articlesVertex Pharmaceuticals has climbed to fresh highs, fueled by a robust cystic fibrosis portfolio and strong cash flow....
A biotech stock can surge on hype, but smart investors dig into the data behind the rally. This guide breaks down how...
A sizable Hershey share sale by the milton hershey school trust sparks questions about insider activity and stock imp...
Amgen has navigated headwinds to chart a path toward renewed growth. This analysis breaks down the catalysts, risks, ...
A notable insider maneuver at CareDx drew attention to the stock. This article breaks down the sale, what it means fo...
An accessible analysis of what this $405,000 bj's insider sale means for investors, plus practical steps to read insi...
Pfizer faces a trio of headwinds: a CFO departure, a clinical miss, and a billion-dollar bet on Seagen. This article ...
A recent FDA decision sparked a powerful rally in Moderna shares, but is the move enough to call it a no-brainer? Thi...
A biotech stock nearly 300% pop grabbed the attention of major investors, culminating in a $68.7 million stake as a b...
When a top executive sells stock, the market takes notice. This deeper look at Bristow Group's just sold helps you se...
When a chief financial officer liquidates shares, investors pay attention. This article digs into maplight's just sol...
NuScale Power faces a high-stakes decade as regulators, financiers, and utilities weigh SMR potential. This article l...